[1]
K. Szklener, K. Piwowar, J. Klas, N. Kluz, and S. Mańdziuk, “Unexpectedly long progression-free time in a patient with squamous cell carcinoma of the lung treated with Nivolumab – a case study”, J Educ Health Sport, vol. 12, no. 8, pp. 509–517, Aug. 2022.